Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Norditropin for Left Ventricular Mass in Adult GHD
NCT01562834Phase 4Completed
- Sponsor
- Novo Nordisk
- Start
- Oct 1998
- Primary completion
- Dec 2002
- Modality
- Hormone, rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
A Phase 4 trial of somatropin in adult growth hormone deficiency (AGHD), sponsored by Novo Nordisk. Started Oct 1998; status: completed.
02
Drugs
somatropin
03
Conditions
adult growth hormone deficiency (AGHD)
Beyond the preview
Go deeper on NCT01562834.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01562834.